Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Share News (IQAI)

  • There is currently no data for IQAI

IQ-AI News

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM
2 May 2025

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM

IQ-AI Ltd - London-based medical services company - Says subsidiary Imaging Biometrics LLC has applied for breakthrough therapy designation from the U...

IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis
3 Feb 2025

IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis

IQ-AI Ltd - London-based medical services company - Amends existing distribution agreement with artificial intelligence platform provider Blackford An...

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities
22 Jan 2025

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities

IQ-AI Ltd - London-based medical services company - Provides operations update focusing on artificial intelligence. Explains radiology leads the way i...

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown
14 Oct 2024

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown

IQ-AI Ltd - parent of Wisconsin-based Imaging Biometrics LLC, which provides quantitative imaging platforms and therapeutics for the diagnosis and tre...

TRADING UPDATES: NetScientific loss narrows; Vinanz ups Bitcoin fleet
16 Aug 2024

TRADING UPDATES: NetScientific loss narrows; Vinanz ups Bitcoin fleet

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and Wednesday and not separately reported by Al...

IN BRIEF: IQ-AI subsidiary opens expanded access programme
25 Jun 2024

IN BRIEF: IQ-AI subsidiary opens expanded access programme

IQ-AI Ltd - London-based medical services company - US-based subsidiary Imaging Biometrics LLC says that US Food & Drug Administration has approved an...

IQ-AI team begins defining phase 2 protocol for oral gallium maltolate
14 Jun 2024

IQ-AI team begins defining phase 2 protocol for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Friday said the clinical team has started a phase 2 protocol for its oncology-focused drug oral gallium maltolate, whic...

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact
23 May 2024

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: